雜志介紹

Chemotherapy雜志介紹

《Chemotherapy》是一本以English為主的未開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱化療，本刊主要出版、報(bào)道醫(yī)學(xué)-ONCOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為2，最新CiteScore 指數(shù)為5.8。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Ginsenoside-Rg5 Inhibits Retinoblastoma Proliferation and Induces Apoptosis through Suppressing BCL2 Expression.

  Author: Cui Y¹, Su Y¹, Deng L¹, Wang W².

• Relative Factors Analysis of Imatinib Trough Concentration in Chinese Patients with Gastrointestinal Stromal Tumor.

  Author: Wu X¹, Li J², Zhou Y², Mao Y³, Luo S⁴, He X⁵, Wang L⁶, Shen Y⁷, Zhang H¹, Yang L¹, Zhang J⁸.

• Overexpression of TEL-MN1 Fusion Enhances Resistance of HL-60 Cells to Idarubicin.

  Author: Gong S¹, Guo M¹, Tang G¹, Yang J¹, Qiu H².

• IL1RN Polymorphisms Are Associated with a Decreased Risk of Esophageal Cancer Susceptibility in a Chinese Population.

  Author: Wang T¹, Feng Y², Zhao Z³, Wang H⁴, Zhang Y¹, Zhang Y¹, Liu H¹, Jin T⁵, Liu Q⁶.

英文介紹

Chemotherapy雜志英文介紹

This journal publishes original research articles and state-of-the-art reviews on all aspects of antimicrobial and antitumor chemotherapy. The results of experimental and clinical investigations into the microbiological and pharmacologic properties of antibacterial, antiviral and antitumor compounds are major topics of publication. Papers selected for the journal offer data concerning the efficacy, toxicology, and interactions of new drugs in single or combined applications. Studies designed to determine the pharmacokinetic and pharmacodynamics properties of similar preparations and comparing their efficacy are also included. Special emphasis is given to the development of drug-resistance, an increasing problem worldwide.